ATE451102T1 - Thiazol-derivate zur verwendung als entzündungshemmende mittel - Google Patents
Thiazol-derivate zur verwendung als entzündungshemmende mittelInfo
- Publication number
- ATE451102T1 ATE451102T1 AT01943850T AT01943850T ATE451102T1 AT E451102 T1 ATE451102 T1 AT E451102T1 AT 01943850 T AT01943850 T AT 01943850T AT 01943850 T AT01943850 T AT 01943850T AT E451102 T1 ATE451102 T1 AT E451102T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- unsubstituted
- hydrogen
- inflammatory agents
- thiazole derivatives
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 150000007979 thiazole derivatives Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000007577 5-membered cyclic compounds Chemical class 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000003979 eosinophil Anatomy 0.000 abstract 1
- -1 etc. Chemical class 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000198074 | 2000-06-30 | ||
| PCT/JP2001/005540 WO2002002542A1 (fr) | 2000-06-30 | 2001-06-28 | Compose annulaire a cinq chainons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE451102T1 true ATE451102T1 (de) | 2009-12-15 |
Family
ID=18696291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01943850T ATE451102T1 (de) | 2000-06-30 | 2001-06-28 | Thiazol-derivate zur verwendung als entzündungshemmende mittel |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6919361B2 (de) |
| EP (2) | EP1300401B1 (de) |
| JP (1) | JP3785397B2 (de) |
| KR (2) | KR100758775B1 (de) |
| CN (2) | CN1944417A (de) |
| AT (1) | ATE451102T1 (de) |
| AU (2) | AU6634501A (de) |
| CA (1) | CA2413000C (de) |
| CY (1) | CY1109863T1 (de) |
| DE (1) | DE60140748D1 (de) |
| DK (1) | DK1300401T3 (de) |
| ES (1) | ES2336425T3 (de) |
| PT (1) | PT1300401E (de) |
| TW (1) | TWI313266B (de) |
| WO (1) | WO2002002542A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002361117A1 (en) * | 2001-12-28 | 2003-07-24 | Sumitomo Pharmaceuticals Co., Ltd. | 5-membered cyclic compounds |
| EP1348433A1 (de) * | 2002-03-28 | 2003-10-01 | Warner-Lambert Company LLC | Thiazol-5-yl-imine als PDE7-Inhibitoren |
| DE10254336A1 (de) * | 2002-11-21 | 2004-06-03 | Merck Patent Gmbh | Carbonsäureamide |
| WO2005000825A1 (ja) * | 2003-06-27 | 2005-01-06 | Dainippon Sumitomo Pharma Co., Ltd. | チアゾールイミン類およびオキサゾールイミン類 |
| EP2187396B1 (de) * | 2003-10-10 | 2019-03-27 | Sharp Kabushiki Kaisha | Wiedergabevorrichtung, Wiedergabeverfahren, System, Software und computerlesbares Aufzeichnungsmedium, das Software speichert für die Priorisierung der Wiedergabesteuerinformation |
| MY162179A (en) * | 2004-04-01 | 2017-05-31 | Elan Pharm Inc | Steroid sparing agents and methods of using same |
| EP1820504A1 (de) * | 2004-11-15 | 2007-08-22 | Taisho Pharmaceutical Co., Ltd | Iminverbindung |
| EP1875915A4 (de) * | 2005-04-28 | 2010-11-17 | Dainippon Sumitomo Pharma Co | Therapeutikum für chronische obstruktive lungenerkrankung |
| JP2007015999A (ja) * | 2005-07-11 | 2007-01-25 | Sumitomo Chemical Co Ltd | イミノチアゾール化合物の製造方法 |
| AU2006343735A1 (en) * | 2006-05-11 | 2007-11-22 | Dainippon Sumitomo Pharma Co., Ltd. | A medicament containing a thiazole derivative as an active ingredient |
| CA2647598A1 (en) | 2006-05-31 | 2007-12-06 | Abbott Laboratories | Compounds as cannabinoid receptor ligands and uses thereof |
| US8841334B2 (en) | 2006-05-31 | 2014-09-23 | Abbvie Inc. | Compounds as cannabinoid receptor ligands and uses thereof |
| CN101765594A (zh) | 2007-03-28 | 2010-06-30 | 雅培制药有限公司 | 作为大麻素受体配体的1,3-噻唑-2(3h)-亚基化合物 |
| US7872033B2 (en) | 2007-04-17 | 2011-01-18 | Abbott Laboratories | Compounds as cannabinoid receptor ligands |
| JP2010527929A (ja) | 2007-05-18 | 2010-08-19 | アボット・ラボラトリーズ | カンナビノイド受容体リガンドとしての新規な化合物 |
| KR100863239B1 (ko) | 2007-05-23 | 2008-10-15 | 한국과학기술연구원 | 신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는ｔ-형 칼슘 채널 저해제 |
| US9193713B2 (en) | 2007-10-12 | 2015-11-24 | Abbvie Inc. | Compounds as cannabinoid receptor ligands |
| WO2009131171A1 (ja) | 2008-04-25 | 2009-10-29 | 大日本住友製薬株式会社 | 新規５員環化合物 |
| EP2272844A4 (de) * | 2008-04-25 | 2012-02-22 | Dainippon Sumitomo Pharma Co | Fünfgliedrige ringverbindung |
| US8846730B2 (en) | 2008-09-08 | 2014-09-30 | Abbvie Inc. | Compounds as cannabinoid receptor ligands |
| AU2009293319A1 (en) | 2008-09-16 | 2010-03-25 | Abbott Laboratories | Substituted benzamides as cannabinoid receptor ligands |
| PA8854001A1 (es) | 2008-12-16 | 2010-07-27 | Abbott Lab | Compuestos novedosos como ligandos de receptores de canabinoides |
| US8492371B2 (en) | 2009-03-27 | 2013-07-23 | Abbvie Inc. | Compounds as cannabinoid receptor ligands |
| WO2014052831A1 (en) * | 2012-09-28 | 2014-04-03 | Xavier University Of Louisiana | Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE941288C (de) | 1950-10-31 | 1956-04-05 | Goodrich Co B F | Verfahren zur Herstellung substituierter 2-Imino-4-thiazoline oder von Salzen derselben bzw. von substituierten 2-Aminothiazolen |
| EP0848059A1 (de) | 1996-12-12 | 1998-06-17 | Vetigen | ICYP (Iodocyanopindolol) Rezeptor von Säugetieren und dessen Anwendungen |
| US7076307B2 (en) * | 2002-05-09 | 2006-07-11 | Boveja Birinder R | Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders |
| FR2796643B1 (fr) * | 1999-07-22 | 2005-04-29 | Sod Conseils Rech Applic | Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique |
| EP1237849A1 (de) * | 1999-11-05 | 2002-09-11 | University College London | Aktivatoren der löslichen guanylatcyclase |
| US20030208212A1 (en) * | 1999-12-07 | 2003-11-06 | Valerio Cigaina | Removable gastric band |
| DE19959825C1 (de) * | 1999-12-10 | 2001-07-26 | Dorma Gmbh & Co Kg | Schiebewand mit mehreren seitlich verschiebbaren Wandelementen |
| US6885888B2 (en) * | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
| US6708064B2 (en) * | 2000-02-24 | 2004-03-16 | Ali R. Rezai | Modulation of the brain to affect psychiatric disorders |
| US6639077B2 (en) * | 2000-03-23 | 2003-10-28 | Merck Frosst Canada & Co. | Tri-aryl-substituted-ethane PDE4 inhibitors |
| US6684105B2 (en) * | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
| US7054686B2 (en) * | 2001-08-30 | 2006-05-30 | Biophan Technologies, Inc. | Pulsewidth electrical stimulation |
| EP1476221A4 (de) * | 2002-02-01 | 2008-04-23 | Cleveland Clinic Foundation | Verstellbare simulierungsvorrichtung und verwendungsverfahren dafür |
| US7831308B2 (en) * | 2002-02-01 | 2010-11-09 | The Cleveland Clinic Foundation | Neural stimulation delivery device with independently moveable delivery structures |
| AU2003210752A1 (en) * | 2002-02-01 | 2003-09-02 | The Cleveland Clinic Foundation | Modulation of the pain circuitry to affect chronic pain |
| US7689276B2 (en) * | 2002-09-13 | 2010-03-30 | Leptos Biomedical, Inc. | Dynamic nerve stimulation for treatment of disorders |
| US20040015205A1 (en) * | 2002-06-20 | 2004-01-22 | Whitehurst Todd K. | Implantable microstimulators with programmable multielectrode configuration and uses thereof |
| US7292890B2 (en) * | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
| US20040210270A1 (en) * | 2002-07-26 | 2004-10-21 | John Erickson | High frequency pulse generator for an implantable neurostimulator |
| US7209790B2 (en) * | 2002-09-30 | 2007-04-24 | Medtronic, Inc. | Multi-mode programmer for medical device communication |
| US7844338B2 (en) * | 2003-02-03 | 2010-11-30 | Enteromedics Inc. | High frequency obesity treatment |
| US7613515B2 (en) * | 2003-02-03 | 2009-11-03 | Enteromedics Inc. | High frequency vagal blockage therapy |
| US7444183B2 (en) * | 2003-02-03 | 2008-10-28 | Enteromedics, Inc. | Intraluminal electrode apparatus and method |
| US20040172084A1 (en) * | 2003-02-03 | 2004-09-02 | Knudson Mark B. | Method and apparatus for treatment of gastro-esophageal reflux disease (GERD) |
| US7444184B2 (en) * | 2003-05-11 | 2008-10-28 | Neuro And Cardial Technologies, Llc | Method and system for providing therapy for bulimia/eating disorders by providing electrical pulses to vagus nerve(s) |
| US7149574B2 (en) * | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
| US7263405B2 (en) * | 2003-08-27 | 2007-08-28 | Neuro And Cardiac Technologies Llc | System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities |
| US7252090B2 (en) * | 2003-09-15 | 2007-08-07 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using neural network |
| US7184837B2 (en) * | 2003-09-15 | 2007-02-27 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using bayesian networks |
| US7239926B2 (en) * | 2003-09-15 | 2007-07-03 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using genetic algorithms |
| US7617002B2 (en) * | 2003-09-15 | 2009-11-10 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using decision trees |
| US7418292B2 (en) * | 2003-10-01 | 2008-08-26 | Medtronic, Inc. | Device and method for attenuating an immune response |
| CA2573785A1 (en) * | 2004-07-20 | 2006-02-02 | Medtronic, Inc. | Therapy programming guidance based on stored programming history |
-
2001
- 2001-06-28 EP EP01943850A patent/EP1300401B1/de not_active Expired - Lifetime
- 2001-06-28 JP JP2002507796A patent/JP3785397B2/ja not_active Expired - Fee Related
- 2001-06-28 PT PT01943850T patent/PT1300401E/pt unknown
- 2001-06-28 ES ES01943850T patent/ES2336425T3/es not_active Expired - Lifetime
- 2001-06-28 CA CA002413000A patent/CA2413000C/en not_active Expired - Fee Related
- 2001-06-28 DK DK01943850.6T patent/DK1300401T3/da active
- 2001-06-28 KR KR1020027017947A patent/KR100758775B1/ko not_active Expired - Fee Related
- 2001-06-28 CN CNA2006100818928A patent/CN1944417A/zh active Pending
- 2001-06-28 AT AT01943850T patent/ATE451102T1/de active
- 2001-06-28 AU AU6634501A patent/AU6634501A/xx active Pending
- 2001-06-28 WO PCT/JP2001/005540 patent/WO2002002542A1/ja not_active Ceased
- 2001-06-28 EP EP05025661A patent/EP1669070A3/de not_active Withdrawn
- 2001-06-28 KR KR1020077015693A patent/KR100824156B1/ko not_active Expired - Fee Related
- 2001-06-28 DE DE60140748T patent/DE60140748D1/de not_active Expired - Lifetime
- 2001-06-28 US US10/312,692 patent/US6919361B2/en not_active Expired - Fee Related
- 2001-06-28 CN CNB018146139A patent/CN100369903C/zh not_active Expired - Fee Related
- 2001-06-28 AU AU2001266345A patent/AU2001266345B2/en not_active Ceased
- 2001-06-29 TW TW090115944A patent/TWI313266B/zh not_active IP Right Cessation
-
2005
- 2005-04-22 US US11/111,845 patent/US7396842B2/en not_active Expired - Fee Related
-
2010
- 2010-03-02 CY CY20101100202T patent/CY1109863T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3785397B2 (ja) | 2006-06-14 |
| KR20070086998A (ko) | 2007-08-27 |
| KR20030011377A (ko) | 2003-02-07 |
| CN1944417A (zh) | 2007-04-11 |
| AU6634501A (en) | 2002-01-14 |
| US7396842B2 (en) | 2008-07-08 |
| EP1300401A1 (de) | 2003-04-09 |
| DE60140748D1 (de) | 2010-01-21 |
| PT1300401E (pt) | 2010-01-25 |
| US20040072827A1 (en) | 2004-04-15 |
| KR100758775B1 (ko) | 2007-09-14 |
| US20050222226A1 (en) | 2005-10-06 |
| AU2001266345B2 (en) | 2006-03-02 |
| CN1620442A (zh) | 2005-05-25 |
| EP1669070A2 (de) | 2006-06-14 |
| CY1109863T1 (el) | 2014-09-10 |
| WO2002002542A1 (fr) | 2002-01-10 |
| EP1300401B1 (de) | 2009-12-09 |
| CA2413000C (en) | 2010-01-19 |
| DK1300401T3 (da) | 2010-02-01 |
| CA2413000A1 (en) | 2002-01-10 |
| ES2336425T3 (es) | 2010-04-13 |
| EP1669070A3 (de) | 2007-05-23 |
| CN100369903C (zh) | 2008-02-20 |
| US6919361B2 (en) | 2005-07-19 |
| EP1300401A4 (de) | 2004-07-21 |
| KR100824156B1 (ko) | 2008-04-21 |
| TWI313266B (en) | 2009-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109863T1 (el) | Παραγωγα θειαζολης για χρηση ως αντιφλεγμονωδη | |
| ATE275134T1 (de) | 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel | |
| ATE156816T1 (de) | Multiwirkstoffresistenz-umkehrende mittel | |
| EP0754688A3 (de) | Dioxolanzwischenprodukten | |
| DE60315265D1 (de) | Stickstoffhaltige heterocyclische verbindung und arzneimittel davon | |
| DE69918404D1 (de) | Aminophenoxyessigsäure derivate als neuroschützende mittel | |
| DK0906907T3 (da) | Forbindelser, der potenserer retinoid | |
| ES2166359T3 (es) | Derivado de depsipeptido, su produccion y uso. | |
| WO2003016291A1 (en) | ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ | |
| DE3889345D1 (de) | Schimmelbekämpfungsmittel. | |
| DK0976748T3 (da) | Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet | |
| ATE282614T1 (de) | Phenylharnstoff und phenylthioharnstoffderivate | |
| DE69918695D1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| LV10076A (lv) | Aizvietoti beta- diketoni | |
| FI940425A0 (fi) | Modifioidut oligodeoksiribonukleotidit, niiden valmistus ja niiden terapeuttinen käyttö | |
| ATE274903T1 (de) | Antivirale mittel | |
| DE69915514D1 (de) | Prenyltransferase-inhibitoren | |
| DE69017774D1 (de) | Benzothiazol-derivate als fungizide. | |
| NO972731D0 (no) | Thiazolidinonforbindelser eller middel inneholdende disse for å behandle eller forhindre angina pectoris | |
| DE69017627D1 (de) | Isochinolinderivate und ihre Salze als Proteasehemmer. | |
| DK0583806T3 (da) | Acrylderivater af 2-thiazolylpyrroler med fungicid aktivitet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1300401 Country of ref document: EP |